← Back to home

FDA Grants Accelerated Approval to GSK's Nelkarmi for ALK-Positive Lung Cancer

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

Regulators granted conditional approval on Nov. 17, 2026, to Nelkarmi, a daily pill from…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

5 confirmed facts, 1 open question and 2 sources behind this story.

About this story

We haven’t published a correction to this story.

How NewsPlain works
← Back to home